EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025 EBX-102 was well tolerated and showed multiple positive trends over placeboFindings support progression…
Initiates Phase 2 platinum-resistant ovarian cancer trialHELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company…
Donato Spota Donato Spota Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously…
Herantis Pharma Plc – Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for…
The partnership supports seamless, secure payments through Quadient’s AR and AP solutions for businesses across North America, the UK and…
Reykjavík, May 13, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) 2024 Exploration Update for Strategic Minerals…
Nilfisk CEO, Jon Sintorn, comments on Q1 results: “The first quarter saw high activity and strong focus on execution. Geopolitical…
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative…
Long term follow-up in this curative setting demonstrated clinically meaningful survival benefit when adding adjuvant Perjeta® (pertuzumab) to Herceptin® (trastuzumab)…
EfTEN Real Estate Fund AS earned strong financial results in April. Consolidated rental income reached 2,611 thousand euros, increasing by…
This website uses cookies.